Patent Assignment
Reel/Frame 058741/0483
Change of Name
Recorded: 2022-01-14
Pages: 3
Assignor
KALIVIR IMMUNOTHERAPEUTICS LLC
Executed: 2021-04-01
Assignee
KALIVIR IMMUNOTHERAPEUTICS, INC.
240 ALPHA DRIVE, PITTSBURGH, PENNSYLVANIA, 15238
Covered Property
(1)
Platform Oncolytic Vector for Systemic Delivery
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.